Sterile Parenteral Compounding

Aseptic manufacturing of parenteral drug products

Our innovative approach enables rapid development and manufacturing of sterile solution formulations for parenteral administration.

With more than 30 years of experience in the development of parenteral drug products, we are able to support your programs from candidate development through clinical trial manufacturing via aseptic filtration techniques. Our innovative approach enables rapid development and manufacturing of sterile solution formulations for parenteral administration, with a strong emphasis on environmental and process controls to ensure the safety of your therapy.

Sterile Parenteral Compounding

Customized services for manufacturing your therapy

Parenteral drug products, which include intravenous (IV), subcutaneous (SC), or intramuscular (IM) routes of administration, require careful planning, thoroughly trained personnel, and dedicated facilities to ensure patient safety. At our state-of-the-art facilities, we have the expertise to develop, pharmacy compound, manufacture, test, release, and supply a range of formulations (IV, SC, and IM administration) for a variety of clinical study types, including first-in-human (FIH) healthy volunteer studies assessing safety, tolerability, and pharmacokinetics (PK), as well as radiolabeled formulations for human absorption, distribution, metabolism, and excretion (ADME) studies. Utilize our services as a standalone offering or as part of an integrated drug development program tailored to meet your needs.